calcium borate has been researched along with 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide in 1 studies
Studies (calcium borate) | Trials (calcium borate) | Recent Studies (post-2010) (calcium borate) | Studies (2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide) | Trials (2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide) | Recent Studies (post-2010) (2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide) |
---|---|---|---|---|---|
19 | 1 | 12 | 90 | 6 | 21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenton, BM; Lord, EM; Paoni, SF | 1 |
1 other study(ies) available for calcium borate and 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide
Article | Year |
---|---|
Intravascular HBO(2) saturations, perfusion and hypoxia in spontaneous and transplanted tumor models.
Topics: Animals; Borates; Calcium Compounds; Disease Models, Animal; Etanidazole; Female; Hydrocarbons, Fluorinated; Hypoxia; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oxygen; Perfusion; Radiation-Sensitizing Agents | 2001 |